Your browser doesn't support javascript.
loading
FDA Approval Summary: Brentuximab Vedotin in First-Line Treatment of Peripheral T-Cell Lymphoma.
Richardson, Nicholas C; Kasamon, Yvette L; Chen, Haiyan; de Claro, R Angelo; Ye, Jingjing; Blumenthal, Gideon M; Farrell, Ann T; Pazdur, Richard.
Afiliação
  • Richardson NC; Office of Hematology and Oncology Products, Center for Drug Evaluation and Research, Silver Spring, Maryland, USA nicholas.richardson@fda.hhs.gov.
  • Kasamon YL; Office of Hematology and Oncology Products, Center for Drug Evaluation and Research, Silver Spring, Maryland, USA.
  • Chen H; Office of Biostatistics, Center for Drug Evaluation and Research, Silver Spring, Maryland, USA.
  • de Claro RA; Office of Hematology and Oncology Products, Center for Drug Evaluation and Research, Silver Spring, Maryland, USA.
  • Ye J; Office of Biostatistics, Center for Drug Evaluation and Research, Silver Spring, Maryland, USA.
  • Blumenthal GM; Office of Hematology and Oncology Products, Center for Drug Evaluation and Research, Silver Spring, Maryland, USA.
  • Farrell AT; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.
  • Pazdur R; Office of Hematology and Oncology Products, Center for Drug Evaluation and Research, Silver Spring, Maryland, USA.
Oncologist ; 24(5): e180-e187, 2019 05.
Article em En | MEDLINE | ID: mdl-30914464
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 3_ND Base de dados: MEDLINE Assunto principal: Linfoma de Células T Periférico / Antineoplásicos Imunológicos / Brentuximab Vedotin Tipo de estudo: Clinical_trials Limite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País/Região como assunto: America do norte Idioma: En Revista: Oncologist Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 3_ND Base de dados: MEDLINE Assunto principal: Linfoma de Células T Periférico / Antineoplásicos Imunológicos / Brentuximab Vedotin Tipo de estudo: Clinical_trials Limite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País/Região como assunto: America do norte Idioma: En Revista: Oncologist Ano de publicação: 2019 Tipo de documento: Article